Uptake of circulating insulin-like growth factors (IGFs) into cerebrospinal fluid appears to be independent of the IGF receptors as well as IGF-binding proteins

Endocrinology

Volumn 142, Issue 1, 2001, Pages 213-220

  Pulford, Bruce E ^a   Ishii, Douglas N ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN RECEPTOR;

ACTIVE TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN INJURY; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; SENSITIVITY AND SPECIFICITY;

EID: 0035115323     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.1.7894     Document Type: Article

References (53)

1. The developing CNS: A scenario for the action of proinsulin, insulin and insulin-like growth factors
2. The role of insulin-like growth factors in the central nervous system
3. Neuropharmacology of insulin-like growth factors
4. Growth enhancement of transgenic mice expressing human insulin-like growth factor I
5. In vivo actions of insulin-like growth factor-I on brain myellnation: Studies of IGF-I and IGF binding protein-I transgenic mice
6. Insulin and insulinlike growth factor receptors regulating neurite formation in cultured human neuroblastoma cells
7. Insulin, insulin-like growth factor II, and nerve growth factor effects on tubulin mRNA levels and neurite formation
8. Effects of insulin and insulin-like growth factors on neurofilament mRNA and tubulin mRNA content in human neuroblastoma SH-Y5Y cells
9. Effects of insulin, insulin-like growth factor-II and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells
10. Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve
11. Insulin-like growth factor-II increases the rate of sciatic nerve regeneration in rats
12. Insulin-like growth factor-II stimulates motor nerve regeneration
13. Insulin-like growth factor-II increases and IGF is required for postnatal rat spinal motoneuron survival following sciatic nerve axotomy
14. Trophic actions of IGF-I, IGF-II and insulin on chohnergic and dopammergic brain neurons
15. Parental imprinting of the mouse insulin-like growth factor II gene
16. A review of insulin/insulin-like peptide in the central nervous system
17. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage
18. IGF-I supports the survival and/or differentiation of multiple types of central nervous system neurons
19. Insulin-like growth factor I receptors and IGF-I actions in neuronal cultures from the brain
20. A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury
21. Insulin-like growth factor-I improves both neurological motor and cognitive outcome following experimental brain injury
22. Intravenous insulin-like growth factor-I in moderate-to-severe head injury: A phase II safety and efficacy trial
23. Insulin-like growth factor I restores motor coordination in a rat model of cerebellar ataxia
24. Peripherally administered insulin-like growth factor-I preserves hindlimb reflex and spinal cord noradrenergic circuitry following a central nervous system lesion in rats
25. Uptake of circulating insulin-like growth factor-I into the cerebrospinal fluid of normal and diabetic rats and normalization of IGF-II mRNA content in diabetic rat brain
26. Cerebrospinal fluid collection in rats: Modification of a previous technique
27. Role of insulin-like growth factor binding proteins in modifying IGF actions
28. Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3
29. A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide
30. Discrete alterations of the insulin-like growth factor I molecule which alters its affinity for insulin-like growth factor binding proteins in changes in bioactivity
31. Natural and synthetic forms of insulin-like growth factor-1 (IGF-1) and the potent derivative, destripeptide IGF-1: Biological activities and receptor binding
32. The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor
33. Insulin-like growth factors cross the bloodbrain barrier
34. Neuroendocrine regulatory mechanisms in the choroid plexus-cerebrospinal fluid system
35. Transport of iron in the blood-brain-cerebrospinal fluid system
36. Characterization of somatomedins from human fetal brain: Identification of a variant form of insulin-like growth factor I
37. Isolation and characterization of variant IGF-I as well as IGF-2 from adult human brain
38. A comparison of the biological activity of the recombinant intact and truncated insulin-like growth factor I
39. Enhanced potency of truncated insulin-like growth factor-I (des(1-3) IGF-I) relative to IGF-I in lit/lit mice
40. Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels
41. Heterogeneity of IGF-I affinity for the IGF-II receptor: Comparison of natural, synthetic and recombinant DNA-derived IGF-I
42. Human blood-brain barrier insulin-like growth factor receptor
43. The insulin-like growth factor-II/mannose 6-phosphate receptor
44. Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man
45. Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid
46. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo
47. Selective, physiological transport of insulin across the blood-brain barrier: Novel demonstration by species-specific radioimmunoassays
48. Differential permeability of the blood-brain barrier to two pancreatic peptides: Insulin and amylin
49. Seasonal changes in CSF insulin levels in marmots: Insulin may not be a satiety signal for fasting in winter
50. Effects of insulin, insulin-like growth factor-II, and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurons
51. Evidence for two species of insulin-like growth factor II (IGF-II and big IGF-II) in human spinal fluid
52. Somatomedin levels in cerebrospinal fluid from adults with pituitary disorders
53. Brain insulin-like growth factor-II mRNA content is reduced in insulin-dependent and noninsulin-dependent diabetes mellitus